Khagga Bhavyasri | Pharmaceutical Analysis | Best Researcher Award

Posted on by Forensic Scientist

Dr. Khagga Bhavyasri | Pharmaceutical Analysis | Best Researcher Award

RBVRR Women’s college of Pharmacy | India

Dr. K. Bhavyasri is an accomplished academic and researcher in the field of Pharmaceutical Analysis and Quality Assurance, currently serving as an Associate Professor at RBVRR Women’s College of Pharmacy, Hyderabad. With over 12 years of rich teaching and research experience, she has made significant contributions to pharmaceutical sciences through her work in pharmacokinetics, method development, and quality assurance. Her professional ethos combines leadership, perseverance, and a keen scientific acumen, all of which have made her a standout in pharmaceutical academia.

Author Profile👤

Google Scholar

Scopus

Strengths for the Awards✨

Dr. K. Bhavyasri demonstrates exceptional qualifications that position her as a top contender for the “Best Researcher Award”:

  • Academic Excellence: With a Ph.D. in Pharmaceutical Analysis from JNTU Hyderabad and an M.Pharmacy from Osmania University, Dr. Bhavyasri’s educational foundation is rooted in India’s premier institutions.

  • Vast Research Output: Her portfolio boasts 187 international publications, including SCI-indexed and peer-reviewed journals, showcasing her dedication to scholarly excellence.

  • Innovation & IP Contribution: With 10 patents applied, 4 granted, and 6 published, she has demonstrated a strong inclination toward innovation and translational research.

  • Academic Mentorship: Having guided 46 M.Pharmacy and 24 B.Pharmacy projects, along with one Ph.D. scholar (and being recognized as a Ph.D. guide under Osmania University), her mentorship capabilities are clear.

🎓 Education

Dr. Bhavyasri holds a Ph.D. in Pharmaceutical Analysis & Quality Assurance from JNT University, Hyderabad (2016). She earned her M.Pharmacy degree from Osmania University with an impressive 79.45%, and a PG Diploma in Pharmaceutical Quality Assurance & Regulatory Affairs from JNTU-H with 76%. Her academic journey began with a Bachelor’s in Pharmacy from Sulthan-ul-Uloom College of Pharmacy, followed by an Intermediate in Bi.P.C with 84% and schooling under CBSE curriculum with 76%.

🧪 Experience

Dr. Bhavyasri’s academic career spans across several renowned institutions. She currently holds the position of Associate Professor at RBVRR Women’s College of Pharmacy since 2018 and previously served as an Assistant Professor at various institutions, including Sri Siddhartha Pharmacy College, Shadan Women’s College of Pharmacy, and Centre for Pharmaceutical Sciences, JNTU-H. Her cumulative experience of over 12 years and 9 months highlights her deep-rooted involvement in academia and pharmaceutical research.

🔬 Research Interests On Pharmaceutical Analysis

Her research interests revolve around pharmacokinetics, residual solvent analysis, genotoxic impurity profiling, and advanced analytical techniques like LC-MS/MS, HPLC, FT-IR, and Raman Spectroscopy. She has conducted stability studies on antibiotics and CNS drugs and developed novel methods for quantifying critical impurities. She is currently guiding 46 M.Pharmacy and 24 B.Pharmacy students, with one Ph.D. candidate under her mentorship at Vignan University. She is also a recognized Ph.D. guide under Osmania University.

🏆 Awards

Dr. Bhavyasri has received several prestigious awards, including the Best Young Researcher National Award by the IRDP Group of Journals and the Outstanding Scientist Award by VDGOOD Technology Factory. She is also an Associate Fellow of the Andhra Pradesh Science Academy, recognizing her significant impact in pharmaceutical sciences and research.

đź“š Publications

  • ICH guidelines–“Q” series (quality guidelines)-A review
    K Bhavyasri, KM Vishnumurthy, D Rambabu, M Sumakanth
    Year: 2019 | Citations: 40

  • A Review on Comparative study of HPLC and UPLC
    RS Sri, KB Sri, C Mounika
    Year: 2020 | Citations: 33

  • Sustainable cost-effective microalgae harvesting strategies for the production of biofuel and oleochemicals
    S Rakesh, J Tharunkumar, B Sri, K Jothibasu, S Karthikeyan
    Year: 2020 | Citations: 31

  • Home automation using chatbot and voice assistant
    B Kadali, N Prasad, P Kudav, M Deshpande
    Year: 2020 | Citations: 22

  • Vegetable-derived magnesium stearate functionality evaluation by DM3 approach
    RV Haware, VS Dave, B Kakarala, S Delaney, S Staton, E Munson, …
    Year: 2016 | Citations: 22

  • RP-HPLC method for dapagliflozin and metformin HCL in bulk and combined formulation
    K Bhavyasri, T Surekha, S Begum, M Sumakanth
    Year: 2021 | Citations: 13

  • Development and validation of ultra violet-visible spectrophotometric method for estimation of Rivaroxaban in spiked human plasma
    K Bhavyasri, C Dhanalakshmi, M Sumakanth
    Year: 2020 | Citations: 12

  • Bioanalytical method development and validation of milnacipran in rat plasma by LC–MS/MS detection and its application to a pharmacokinetic study
    K Kanala, NT Hwisa, BR Chandu, P Katakam, M Khagga, BR Challa, …
    Year: 2013 | Citations: 12

  • Development and Validation of UV spectroscopy method for the determination of cefpodoxime proxetil and ambroxol hydrochloride in pharmaceutical formulation
    G Abirami, T Vetrichelvan, M Bhavyasri
    Year: 2012 | Citations: 12

  • Development and validation of forced degradation studies of Raltegravir using RP-HPLC and characterization of degradants by LC-MS/MS
    K Bhavyasri, VM Balaram, R Nageswarao, D Rambabu, ES Goud, …
    Year: 2015 | Citations: 11

âś… Conclusion

🌟 With an exceptional academic track record, decades of teaching and research experience, advanced analytical skills, and numerous accolades to her name, Dr. K. Bhavyasri stands out as a prime candidate for an Award in Research Excellence. Her unyielding commitment to pharmaceutical education, innovation in research methodologies, and mentorship of future scientists showcases her merit and continued promise.

Prabhat Singh | Pharmacology | Excellence in Research

Posted on by Forensic Scientist

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

đź“š Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.

Shanbo Ma | Pharmacology | Best Researcher Award

Posted on by Forensic Scientist

Dr. Shanbo Ma | Pharmacology | Best Researcher Award

Deputy Chief Pharmacist | Xijing Hospital of Air Force Medical University | China

Shanbo Ma is a dedicated researcher in the field of Chinese pharmacology, focusing on the pharmacological mechanisms and therapeutic potential of traditional Chinese medicine (TCM). With a strong academic background and extensive research experience, he has contributed significantly to the study of anti-inflammatory effects and active ingredients in TCM. His expertise spans molecular biology, cell biology, and bioinformatics, making him a key figure in integrating computational and experimental approaches to drug discovery.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Research Output & Impact đź“š

    • Published multiple peer-reviewed articles in high-impact journals such as Frontiers in Pharmacology, Journal of Ethnopharmacology, and Journal of Biomolecular Structure & Dynamics.
    • Research spans diverse pharmacological applications, including colorectal cancer, anxiety treatment, ulcerative colitis, and depression, indicating a broad impact in Chinese pharmacology and molecular medicine.
    • Co-first and co-corresponding authorships in multiple papers highlight leadership in research projects.

  • Interdisciplinary Expertise 🔬

    • Skilled in network pharmacology, molecular docking, bioinformatics, and experimental validation, demonstrating a strong foundation in both computational and experimental pharmacology.
    • Expertise in cell biology, molecular biology, and animal experiments, which are critical for translational research in pharmacology.

  • Technical & Analytical Proficiency đź’»

    • Proficient in essential research tools, including GraphPad, Cytoscape, Photoshop, SYBYL, and Image J, supporting advanced data analysis and visualization.

  • Recognition & Awards 🏆

    • Received the Outstanding Paper Award (2023) from the Chinese Pharmaceutical Society, a significant achievement showcasing research excellence.

  • Educational Background & Training 🎓

    • Holds a Ph.D. in Science of Chinese Pharmacology from Northwest University (2020–2024).
    • Completed a Master’s in Chinese Medicine from Shaanxi University of Chinese Medicine and a Bachelor’s in Pharmacology from Bengbu Medical University, providing a solid academic foundation.

🎓 Education

  • đź“Ś 2020.09 – 2024.06 | Northwest University | Doctorate in Science of Chinese Pharmacology
  • đź“Ś 2014.09 – 2017.07 | Shaanxi University of Chinese Medicine | Master’s in Chinese Medicine
  • đź“Ś 2013.09 – 2017.07 | Bengbu Medical University | Bachelor’s in Pharmacology

đź’Ľ Experience

Shanbo Ma has been actively involved in pharmacological research, specializing in the bioactivity screening and mechanistic exploration of TCM. His work integrates network pharmacology, bioinformatics, and molecular docking techniques to elucidate drug mechanisms. He has also demonstrated proficiency in project design and team coordination, leading multiple research initiatives and collaborations.

🔬 Research Interests On Pharmacology

  •  Screening the pharmacological substance basis of traditional Chinese medicine
  •  Investigating the anti-inflammatory effects and mechanisms of TCM and its active ingredients
  •  Utilizing bioinformatics and network pharmacology to analyze drug-target interactions
  •  Exploring molecular docking and experimental validation methods for TCM efficacy

🏆 Awards

  • 🏅 Outstanding Paper Award, Chinese Pharmaceutical Society (2023)

đź“š Publications

  • Elucidation of the mechanism of action of ailanthone in the treatment of colorectal cancer: integration of network pharmacology, bioinformatics analysis and experimental validation

    • Authors: Ma Shanbo, Guo Xiaodi, et al.
    • Publication Year: 2024

  • Glycyrrhizic acid treatment ameliorates anxiety-like behaviour via GLT1 and Per1/2-dependent pathways

    • Authors: Ma Shanbo, Chong Ye, et al.
    • Publication Year: 2024

  • Virtual screening-molecular docking-activity evaluation of Ailanthus altissima (Mill.) swingle bark in the treatment of ulcerative colitis

    • Authors: Ma Shanbo, Liu Lun, et al.
    • Publication Year: 2023

  • Investigating the mechanism of Sinisan formula in depression treatment: a comprehensive analysis using GEO datasets, network pharmacology, and molecular docking

    • Authors: Zheng Meiling, Yang, Shi Xiaopeng#, Ma Shanbo#
    • Publication Year: 2024

  • Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy

    • Authors: Guo Xiaodi, Wang Feiyan, Ma Shanbo#, Shi Xiaopeng#
    • Publication Year: 2023

  • Investigation into the in vivo mechanism of diosmetin in patients with breast cancer and COVID-19 using bioinformatics

    • Authors: Wang Jin*, Ma Shanbo*, et al.
    • Publication Year: 2022

🔬 Skills

  •  Expertise in cell biology, molecular biology, and animal experiments
  •  Proficient in bioinformatics tools such as GraphPad, AI, Photoshop, ImageJ, Cytoscape, and SYBYL
  •  Strong ability to design projects independently and coordinate teamwork

🔚 Conclusion

Shanbo Ma is a passionate and accomplished researcher in Chinese pharmacology, making substantial contributions to understanding the therapeutic mechanisms of traditional medicines. His expertise in network pharmacology, molecular docking, and bioinformatics enhances his ability to uncover novel insights in drug discovery. With numerous publications and an award-winning research portfolio, he continues to drive advancements in the field of traditional medicine research.